Personalis, Inc.
PSNL
$3.40
$0.39513.17%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/31/2025
-
MarketBeat
3/30/2025
-
Ticker Report
3/28/2025
-
Zacks Investment Research
3/26/2025
-
GuruFocus
3/26/2025
-
Business Wire
3/21/2025
-
Simply Wall St
3/18/2025
-
MarketBeat
3/17/2025
-
TipRanks Financial Blog
3/17/2025
-
The Fly
3/17/2025
-
The Fly
3/14/2025
-
ETF Channel
3/3/2025
-
Business Wire
3/2/2025
-
Simply Wall St
3/1/2025
-
MarketBeat
3/1/2025
-
MarketBeat
3/1/2025
-
Ticker Report
3/1/2025
-
MarketBeat
3/1/2025
-
TipRanks Financial Blog
2/28/2025
-
MarketBeat
2/28/2025
-
Market News Video
2/28/2025
-
Benzinga
2/28/2025
-
GuruFocus
2/28/2025
-
GuruFocus
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 752 1300
Address
6600 Dumbarton Circle
Fremont, CA 94555
Fremont, CA 94555
Country
Year Founded
Business Description
Sector
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy...
more
